Stay updated on Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study page now displays the full record for a Phase 3 multiple myeloma trial comparing daratumumab, lenalidomide, and dexamethasone with lenalidomide and dexamethasone, including study details and results information.
    Difference
    84%
    Check dated 2026-11-11T17:35:34.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T15:48:19.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A banner announces upcoming NIH website changes and says the agency is transitioning from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-21T20:33:59.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-14T20:32:34.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T20:50:51.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The study page for NCT02076009 now loads a 403 Forbidden error, replacing the previous study content. The error page indicates access is blocked, removing the trial details, interventions, eligibility criteria, and locations from view.
    Difference
    15%
    Check dated 2026-09-23T21:51:32.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial page.